Surgery Partners ROE 2013-2023 | SGRY
Current and historical return on equity (ROE) values for Surgery Partners (SGRY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Surgery Partners ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2023-12-31 | $-0.01B | $3.04B | -0.40% |
| 2023-09-30 | $-0.03B | $2.99B | -1.15% |
| 2023-06-30 | $-0.05B | $2.98B | -1.97% |
| 2023-03-31 | $-0.09B | $2.94B | -3.63% |
| 2022-12-31 | $-0.05B | $2.94B | -2.37% |
| 2022-09-30 | $-0.03B | $2.11B | -1.53% |
| 2022-06-30 | $-0.03B | $2.04B | -1.53% |
| 2022-03-31 | $-0.04B | $2.01B | -2.15% |
| 2021-12-31 | $-0.08B | $1.97B | -4.91% |
| 2021-09-30 | $-0.09B | $1.55B | -5.79% |
| 2021-06-30 | $-0.14B | $1.53B | -9.62% |
| 2021-03-31 | $-0.15B | $1.55B | -11.12% |
| 2020-12-31 | $-0.16B | $1.32B | -12.05% |
| 2020-09-30 | $-0.18B | $1.23B | -13.74% |
| 2020-06-30 | $-0.13B | $1.31B | -9.84% |
| 2020-03-31 | $-0.12B | $1.33B | -8.70% |
| 2019-12-31 | $-0.11B | $1.38B | -7.94% |
| 2019-09-30 | $-0.24B | $1.39B | -16.70% |
| 2019-06-30 | $-0.24B | $1.42B | -16.44% |
| 2019-03-31 | $-0.24B | $1.45B | -15.84% |
| 2018-12-31 | $-0.24B | $1.46B | -15.11% |
| 2018-09-30 | $-0.12B | $1.58B | -7.46% |
| 2018-06-30 | $-0.12B | $1.60B | -7.50% |
| 2018-03-31 | $-0.10B | $1.64B | -7.58% |
| 2017-12-31 | $-0.08B | $1.67B | -7.88% |
| 2017-09-30 | $-0.02B | $1.71B | -3.30% |
| 2017-06-30 | $0.01B | $0.32B | 2.50% |
| 2017-03-31 | $0.01B | $0.32B | 4.39% |
| 2016-12-31 | $0.01B | $0.33B | 3.21% |
| 2016-09-30 | $0.01B | $0.32B | 3.28% |
| 2016-06-30 | $0.01B | $0.31B | 3.91% |
| 2016-03-31 | $0.00B | $0.29B | 1.32% |
| 2015-12-31 | $0.00B | $0.30B | 2.54% |
| 2015-06-30 | $-0.02B | $0.00B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.098B | $2.743B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $118.437B | 15.37 |
| Cencora (COR) | United States | $47.600B | 19.00 |
| ICON (ICLR) | Ireland | $24.090B | 23.76 |
| DiDi Global (DIDIY) | China | $22.541B | 0.00 |
| Avantor (AVTR) | United States | $16.537B | 22.78 |
| CochLear (CHEOY) | $13.442B | 0.00 | |
| Viatris (VTRS) | United States | $13.316B | 3.80 |
| Revvity (RVTY) | United States | $12.420B | 21.62 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.132B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.852B | 21.60 |
| Medpace Holdings (MEDP) | United States | $11.849B | 43.07 |
| Natera (NTRA) | United States | $10.908B | 0.00 |
| Solventum (SOLV) | United States | $10.653B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.853B | 51.20 |
| Bausch + Lomb (BLCO) | Canada | $5.029B | 19.34 |
| Doximity (DOCS) | United States | $4.699B | 34.99 |
| Organon (OGN) | United States | $4.568B | 4.42 |
| Progyny (PGNY) | United States | $3.148B | 52.82 |
| Sotera Health (SHC) | United States | $3.043B | 14.93 |
| Life Times (LTH) | United States | $2.713B | 29.98 |
| GoodRx Holdings (GDRX) | United States | $2.567B | 130.00 |
| Premier (PINC) | United States | $2.473B | 9.05 |
| Teladoc Health (TDOC) | United States | $2.225B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.137B | 6.91 |
| Agilon Health (AGL) | United States | $2.052B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.758B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.432B | 0.00 | |
| Agiliti (AGTI) | United States | $1.365B | 22.29 |
| NovoCure (NVCR) | Jersey | $1.297B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.935B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.740B | 7.66 |
| Embecta (EMBC) | United States | $0.590B | 3.89 |
| Auna S.A (AUNA) | Luxembourg | $0.554B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.528B | 0.00 |
| Enhabit (EHAB) | United States | $0.510B | 46.18 |
| MultiPlan (MPLN) | United States | $0.467B | 0.00 |
| CareDx (CDNA) | United States | $0.429B | 0.00 |
| Beauty Health (SKIN) | United States | $0.409B | 0.00 |
| LifeMD (LFMD) | United States | $0.398B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.378B | 0.00 |
| DocGo (DCGO) | United States | $0.350B | 56.00 |
| Sera Prognostics (SERA) | United States | $0.314B | 0.00 |
| ModivCare (MODV) | United States | $0.295B | 3.91 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.240B | 0.00 |
| Sharecare (SHCR) | United States | $0.237B | 0.00 |
| Biodesix (BDSX) | United States | $0.117B | 0.00 |
| So-Young (SY) | China | $0.116B | 39.00 |
| Oncology Institute (TOI) | United States | $0.087B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| NeueHealth (NEUE) | United States | $0.048B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.039B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |